Pyrukynd
Chemical Name | mitapivat |
Dosage Form | Tablet (oral; 5 mg, 20 mg, 50 mg) |
Drug Class | Pruvate kinase activators |
System | Multiple |
Company | Agios Pharmaceuticals |
Approval Year | 2022 |
Indication
- For the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.